Cardiologist Says FDA Is 'Late to the Show' on Teen Vaping Crisis
*By Carlo Versano*
The shocking rise in teen vaping is a public health crisis that the FDA has been slow to address, according to a nationally recognized cardiologist.
Dr. Kevin Campbell, who is also CEO of Pace Mate, a digital cardiac monitoring service, said the [recent study](https://www.cnbc.com/2019/02/11/e-cigarettes-single-handedly-drives-spike-in-teen-tobacco-use-cdc.html) from the CDC that linked vaping to a spike in teen tobacco use shows that more serious steps need to be take. The first step? Get rid of the flavored nicotine "pods," which Campbell said are acting as a gateway for teenage beginner vapers to get hooked on nicotine.
"We don't know the long-term health effects yet," Campbell said. "I can't emphasize that enough."
While popular vape products are unarguably "healthier" than combustible cigarettes, they still involve the delivery of an addictive drug (nicotine), that is known to do damage to the heart and blood vessels. And there is not enough data on the additives and preservatives that go into the pods.
"They may be doing deleterious things to our bodies as well," Campbell said.
One in five American high schoolers now vapes, according to the CDC, which is enough to cause alarm at the FDA. That agency recently announced a crackdown on vaping companies that market to teens, but that's not enough, in Campbell's opinion.
"I think the FDA is a little bit late to the show here," he said. It's going to require a national education program ー think D.A.R.E. for a new era ー that explains the unknowns and risks involved in vaping. "We need to get ahead of it," Campbell said.
For full interview [click here](https://cheddar.com/videos/teen-tobacco-product-use-on-the-rise).
Google notified a number of small and medium-sized customers that potential antitrust bills could have negative impacts on their own businesses. The warning appears to be an effort to drum up enough opposition to give pause to lawmakers before enacting any such legislation.
Anthony Bartolacci, VP of financials of data Sensor Tower, joined Cheddar to talk about Robinhood's massive earnings miss. He attributed part of it to the platform's exposure to cryptocurrency and its lackluster performance in Q3 following volatility. Bartolacci also noted some headwinds from a drop in engagement on the platform due to people returning to work and having less time to day trade contributing to the miss.
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.
Rent the Runway is making its trading debut on the NASDAQ. The fashion company has struggled since the onset of the pandemic, not having turned a profit since 2019. Crunchbase reporter Sophia Kunthara explains how Rent the Runway has had to make necessary changes to its business model in order to keep itself afloat.
As negotiations drag on in Washington, DC over President Biden's social spending bills, Senate Democrats have introduced a new idea to fund Biden's plans: taxing the unrealized capital gains held by billionaires. Barron's reporter Sabrina Escobar joins Cheddar News' Closing Bell, where she explains what's in the billionaire tax proposal, who it will impact, and why it's on the table.
GM exceeded earnings expectations, yet still felt the chip shortage squeeze. Baron's Senior Writer Al Root discussed GM's segue into the electric car car world despite its struggles.
